Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma-Reference-Cited by-同舟云学术

Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma

Published:2018-03 Issue:2 Volume:17 Page:399-406
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Stahl John M.,Damast Shari,Bledsoe Trevor J.,An Yi,Verma Vivek,Yu James B.,Young Melissa R.,Lester-Coll Nataniel H.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference33 articles.

1. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma;Creutzberg;Int J Radiat Oncol Biol Phys,2011

2. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study;Keys;Gynecol Oncol,2004

3. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients;Aalders;Obstet Gynecol,1980

4. Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis;Gupta;Gynecol Oncol,2017

5. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial;Nout;Lancet,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical brachytherapy solutions to an age-old quandary;Technical Innovations & Patient Support in Radiation Oncology;2020-12

2. The Cost-Effectiveness and Value Proposition of Brachytherapy;Seminars in Radiation Oncology;2020-01

3. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer;International Journal of Gynecologic Cancer;2019-07-17

4. Improving brachytherapy efficiency with dedicated dosimetrist planners;Brachytherapy;2019-01